Kuehn Law Encourages UMBF, ALIM, TBNK, and BEST Investors to Contact Law Firm
Kuehn Law Encourages UMBF, ALIM, TBNK, and BEST Investors to Contact Law Firm
PR Newswire
NEW YORK, June 26, 2024
NEW YORK, June 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- UMB Financial Corporation (NASDAQ: UMBF) Click to Learn More
UMB Financial Corporation has agreed to acquire Heartland Financial in an all-stock transaction valued at around $2 billion.
- Alimera Sciences, Inc. (NASDAQ: ALIM) Click to Learn More
Alimera Sciences, Inc. has agreed to sell to ANI Pharmaceuticals, Inc. for $5.50 per share in cash at closing, plus a non-tradable contingent value right for up to $0.50 per share if specific net revenue targets are met in 2026 and 2027.
- Territorial Bancorp, Inc. (NASDAQ: TBNK) Click to Learn More
Territorial Bancorp Inc. has agreed to be acquired by Hope Bancorp, Inc., with each Territorial share exchanged for 0.8048 shares of Hope common stock. After the transaction, Territorial shareholders will own about 5.6% of the combined company.
- BEST Inc. (NYSE: BEST) Click to Learn More
BEST, Inc. has entered into a definitive agreement to merge with BEST Global Partners and Phoenix Global Partners for $2.88 in cash per American Depository Share.
Why Your Participation Matters:
SHAREHOLDER CASES: ADDRESSING THE INJUSTICE
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
SOURCE Kuehn Law, PLLC
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY48925&Transmission_Id=202406260707PR_NEWS_USPR_____NY48925&DateId=20240626)
-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
What a Strong Economy Now Means for the Rest of 2024
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks